Rational algorithm for imaging techniques in multiple myeloma in the Czech Republic
Authors:
J. Minařík 1; J. Hrbek 2; M. Mysliveček 3; P. Krhovská 1; T. Pika 1; J. Bačovský 1; I. Metelková 3; M. Heřman 2; V. Ščudla 1
Authors‘ workplace:
Hemato-onkologická klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice v Olomouci
1; Radiologická klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice v Olomouci
2; Klinika nukleární medicíny, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice v Olomouci
3
Published in:
Transfuze Hematol. dnes,21, 2015, No. 4, p. 200-205.
Category:
Comprehensive Reports, Original Papers, Case Reports
Overview
Imaging techniques are a fundamental part of multiple myeloma assessment. All diagnostics, certain staging systems and decisions regarding adequate treatment including surgery or radiotherapy are based on imaging techniques. For a very long time, conventional radiography was acknowledged to be the „golden standard“. Conventional radiography is generally accessible but it has several drawbacks including insufficient sensitivity in some areas. Modern imaging techniques such as computed tomography, magnetic resonance imaging or positron emission tomography are more sensitive and provide new and in some aspects unique information. However, they remain less accessible and more expensive. Therefore, careful deliberation is needed when selecting each of these modalities. On the other hand, the choice of adequate imaging technique should not be driven solely by expenses but rather by patient needs. The aim of our paper is to present the advantages of individual imaging techniques based on our previous studies in order to define their role in multiple myeloma diagnostics in the form of rational diagnostic algorithm.
Key words:
multiple myeloma, imaging techniques, conventional radiography, computed tomography, magnetic resonance, positron emission tomography, low-dose computed tomography
Sources
1. Dimopoulos M, Terpos E, Comenzo RL, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia 2009; 23: 1545–1556.
2. Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538–548.
3. Terpos E, Moulopoulos LA, Dimopoulos MA. Advances in imaging and the management of myeloma bone disease. J Clin Oncol 2011; 29: 1907–1915.
4. Ščudla V. Postižení pohybového systému u mnohočetného myelomu. In Rovenský J, et al. Reumatológia v teórii a praxi VI. 1. vydání, Martin, Osveta, 2004: 582–638.
5. Vaníček J, Krupa P, Adam Z. Přínos jednotlivých zobrazovacích metod pro diagnostiku a sledování aktivity mnohočetného myelomu. Vnitř Lék 2010; 56: 585–590.
6. Healy CF, Murray JG, Eustace SJ, et al. Multiple myeloma: a review of imaging features and radiological techniques. Bone Marrow Res, 2011: 583.
7. Bartel TB, Haessler J, Brown TL, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 2009; 114: 2068–2076.
8. Lütje S, de Rooy JW, Croockewit S, et al. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol 2009; 88: 1161–1168.
9. Hanrahan CJ, Christensen CR, Crim JR. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics, 2010; 30: 127–142.
10. Zamagni E, Cavo M. The role of imaging techniques in the management of multiple myeloma. Br J Haematol 2012; 159: 499–513.
11. Walker RC, Brown TL, Jones-Jackson LB, et al. Imaging of multiple myeloma and related plasma cell dyscrasias. J Nucl Med 2012; 53: 1091–1101.
12. Ippolito D, Besostri V, Bonaffini PA, et al. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM). Eur J Radiol 2013; 82: 2322–2327.
13. Myslivecek M, Nekula J, Bacovsky J, et al. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy. Nucl Med Rev Cent East Eur 2008; 11: 12–16.
14. Bacovsky J, Myslivecek M, Scudla V, et al. Tc-99m MIBI scintigraphy in multiple myeloma: Prognostic value of different Tc-99m MIBI uptake patterns. Clin Nucl Med 2010; 35: 667–670.
15. Mysliveček M, Bačovský J, Ščudla V, et al. 18FDG PET/CT v diagnostice mnohočetného myelomu a monoklonální gamapatie nejistého významu: srovnání s 99mTc-MIBI scintigrafií. Klin Onkol 2010; 23: 325–331.
16. Heřman M, Hrbek J, Ščudla V, et al. Korelace nálezů celotělové MR se stážovacím systémem Durie/Salmon u pacientů s monoklonální gamapatií nejistého významu a mnohočetným myelomem. Čes Radiol 2010; 64: 203–212.
17. Ščudla V, Heřman M, Mysliveček M. Současné možnosti diagnostiky myelomové kostní nemoci. Onkologie 2011; 5: 131–137.
18. Ščudla V, Heřman M, Minařík J, et al. Přínos celotělové magnetické rezonance v diagnostice monoklonální gamapatie nejistého významu, mnohočetného myelomu a stanovení stádia pokročilosti nemoci s pomocí systému Durie-Salmon Plus. Vnitř Lék 2011; 57: 52–60.
19. Ščudla V, Heřman M, Minařík J, et al. Přínos celotělové magnetické rezonance v diagnostice monoklonální gamapatie nejistého významu a mnohočetného myelomu. Klin Biochem Metab 2011; 19: 72–78.
20. Minarik J, Scudla V, Bacovsky J, et al. Comparison of imaging methods in POEMS syndrome. Biomed Pap 2012; 156: 52–57.
21. Minařík J, Hrbek J, Pika T, et al. Srovnání přínosu konvenčního RTG, celotělové magnetické rezonance a celotělového nízkodávkového CT v diagnostice myelomové kostní nemoci. Osteol bulletin 2013; 4: 143–147.
22. Pika T, Minařík J, Prášil V, et al. Solitární kostní plazmocytom. Osteol bulletin 2013; 17: 136–142.
23. Minarik J, Hrbek J, Pika T, et al. X-Ray in Multiple Myeloma – Not a “Golden Standard” any More: Case Series. J Bone Mar Res 2014; 2: 1–4. doi: 10.4172/2329-8820.1000149.
24. Hrabálek L, Wanek T, Minařík J, et al. Algoritmus operací mnohočetného myelomu a solitárního plazmocytomu páteře. Cesk Slov Neurol N 2015; 78: 64–71.
25. Bacovsky J, Myslivecek M, Minarik J, et al. Analysis of thymidine kinase serum levels by novel method DiviTumTM in multiple myeloma and monoclonal gammopathy of undetermined significance – comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT. Biomed Pap 2015; 159: 135–138.
26. Keats JJ, Chesi M, Egan JB, et al. Clonal competition with alternating dominance in multiple myeloma. Blood 2012; 120: 1067–1076.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2015 Issue 4
Most read in this issue
- Iron metabolism in blood donors
- Hereditary amyloidosis – aetiology, clinical features and treatment options
- The cytomorphology and immunophenotype of mantle-cell lymphoma
- The role of rituximab maintenance in elderly patients with mantle cell lymphoma in first remission – single centre experience